Evidence map›Paper›PMID 15972952›Full record

ArticleThe American journal of pathology2005

Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing.

Olivera Stojadinovic, Harold Brem, Constantinos Vouthounis, Brian Lee, John Fallon, Michael Stallcup, Ankit Merchant, Robert D Galiano, Marjana Tomic-Canic

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 182 papers.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 355 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. ACS omega · 2026
    Article
  7. Review
  8. Article
  9. Use of thermal imaging in the detection of the diabetic foot- review.Reviews in endocrine & metabolic disorders · 2026
    Review
  10. Review
  11. Review
  12. Dysregulated NAMPT signaling underlines the immune-suppressive microenvironment in venous leg ulcers.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Polyphenols in wound healing: unlocking prospects with clinical applications.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  19. Article
  20. Article

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Olivera StojadinovicThe Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 550 First Ave., TH100, New York, NY 10016, USA.
Harold Brem
Constantinos Vouthounis
Brian Lee
John Fallon
Michael Stallcup
Ankit Merchant
Robert D Galiano
Marjana Tomic-Canic
New York University · USColumbia University · USUniversity of Southern California · US

Funding

Transcription activation by nuclear coactivatorsR01DK043093 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI STALLCUP, MICHAEL R · 1990 to 2019
$6.5M
Epidermal Genes and Their Regulators in Wound HealingR01NR008029 · NINR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TOMIC-CANIC, MARJANA · 2003 to 2007
$1.7M
GLUCOCORTICOIDS IN EPIDERMIS: MECHANISMS OF ACTIONR01AR045974 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TOMIC-CANIC, MARJANA · 2000 to 2004
$960k
Local Angiogenic Therapy for Diabetic UlcersK08DK059424 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BREM, HAROLD · 2002 to 2006
$644k
NIAMS NIH HHS AR45974NIAMS NIH HHS R01 AR045974NIDDK NIH HHS DK43093NIDDK NIH HHS K08 DK059424NIDDK NIH HHS R01 DK043093NINR NIH HHS NR08029NINR NIH HHS R01 NR008029PHS HHS T3207190
6 · The paper itself

Abstract

Lack of understanding of the molecular mechanisms and pathogenesis of impaired healing in chronic ulcers is a serious health issue that contributes to excessive limb amputations and mortality. Here we show that beta-catenin and its downstream targets in keratinocytes, c-myc, and keratins K6 and K16, play important roles in the development of chronic wounds. In contrast to normal epidermis, we observed a significant nuclear presence of beta-catenin and elevated c-myc expression at the nonhealing wound edge of chronic ulcers from 10 patients. In vitro studies indicated that stabilization of nuclear beta-catenin inhibited wound healing and keratinocyte migration by blocking epidermal growth factor response, inducing c-myc and repressing the K6/K16 keratins (cytoskeletal components important for migration). The molecular mechanism of K6/K16 repression involved beta-catenin and arginine methyltransferase (CARM-1) acting as co-repressors of glucocorticoid receptor monomers. We conclude that activation of the beta-catenin/c-myc pathway(s) contributes to impaired healing by inhibiting keratinocyte migration and altering their differentiation. The presence of activated beta-catenin and c-myc in the epidermis of chronic wounds may serve as a molecular marker of impaired healing and may provide future targets for therapeutic intervention.

Indexed as

beta CateninBiomarkersBlotting, NorthernCell DifferentiationCell MovementCells, CulturedCytoskeletal ProteinsEpidermal CellsEpidermal Growth FactorEpidermisHumansImmunohistochemistryIntracellular Signaling Peptides and ProteinsKeratinocytesKeratinsMethyltransferasesbeta CateninBiomarkersCTNNB1 protein, humanCytoskeletal ProteinsEpidermal Growth FactorIntracellular Signaling Peptides and ProteinsKeratinsMethyltransferasesMYC protein, humanPRMT2 protein, humanProtein-Arginine N-MethyltransferasesProto-Oncogene Proteins c-mycTrans-Activators

Identifiers

PMID15972952
PMCPMC1603435
OpenAlexW1497205269

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.